[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341122-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tea-polyphenol-engineered-hybrid-cellular-nanovesicles-for-cancer-immunotherapy-and-androgen-deprivation-therapy","Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy","","Androgen deprivation therapy (ADT) is effective for prostate cancer but systemic dosing can cause severe off-target side effects and can drive resistance. Resistance is associated with activation of NF-κB signaling and high infiltration of M2 macrophages in the tumor microenvironment. The study develops a biomimetic hybrid cellular nanovesicle platform from cancer-cell and probiotic membranes, loading flutamide and modifying with EGCG. In a mouse model, hNVs@Flu-EGCG accumulate in tumors, reprogram M2 to antitumor M1 macrophages, inhibit the NF-κB pathway to promote apoptosis, reduce resistance, and suppress tumor growth by 81.78%.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tea-polyphenol-engineered-hybrid-cellular-nanovesicles-for-cancer-immunotherapy-and-androgen-deprivation-therapy/341122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tea-polyphenol-engineered-hybrid-cellular-nanovesicles-for-cancer-immunotherapy-and-androgen-deprivation-therapy/341122.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is ADT important but limited in prostate cancer treatment?","Question",{"text":63,"@type":64},"ADT is a mainstream approach because it lowers androgen levels and slows disease progression. However, systemic administration can produce significant side effects, and ADT can eventually fail due to castration-resistant progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What mechanisms are linked to ADT resistance in the tumor microenvironment?",{"text":68,"@type":64},"The document links resistance to NF-κB pathway activation and high infiltration of immunosuppressive M2 macrophages in the tumor microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the hNVs@Flu-EGCG platform aim to improve therapeutic outcomes?",{"text":72,"@type":64},"The platform uses hybrid cellular nanovesicles to enhance tumor accumulation, load flutamide to act on androgen receptors, and apply EGCG to inhibit the NF-κB pathway, promote apoptosis, and reprogram M2 macrophages toward an antitumor M1 phenotype.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341122,1790814616,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Guo et al. Journal of Nanobiotechnology (2024) 22:192  \n[https://doi.org/10.1186/s12951-024-02458-9](https://doi.org/10.1186/s12951-024-02458-9)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nTea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy  \nYiming Guo 1,2, Jicheng Wu2,3, Lefan Chen 1, Lujie Liu2, Tianxiang Bi 1, Yuanwei Pan2, Qian-Fang Meng2, Chaoliang Wang 1, Lang Rao2* and Qi Li 1*  \nAbstract  \nAndrogen deprivation therapy (ADT) is a crucial and effective strategy for prostate cancer, while systemic administration may cause profound side effects on normal tissues. More importantly, the ADT can easily lead to resistance by involving the activation of NF-κB signaling pathway and high infiltration of M2 macrophages in tumor microenvironment (TME) . Herein, we developed a biomimetic nanotherapeutic platform by deriving cell membrane nanovesicles from cancer cells and probiotics to yield the hybrid cellular nanovesicles (hNVs), loading flutamide (Flu) into the resulting hNVs, and finally modifying the hNVs@Flu with Epigallocatechin-3-gal late (EGCG) . In this nanotherapeutic platform, the hNVs significantly improved the accumulation of hNVs@Flu-EGCG in tumor sites and reprogramed immunosuppressive M2 macrophages into antitumorigenic M1 macrophages, the Flu acted on androgen receptors and inhibited tumor proliferation, and the EGCG promoted apoptosis of prostate cancer cells by inhibiting the NF-κB pathway, thus synergistically stimulating the antitumor immunity and reducing the side effects and resistance of ADT. In a prostate cancer mouse model, the hNVs@Flu-EGCG significantly extended the lifespan of mice with tumors and led to an 81. 78% reduction in tumor growth compared with the untreated group. Overall, the hNVs@Flu-EGCG are safe, modifiable, and effective, thus offering a promising platform for effective therapeutics of prostate cancer.  \nKeywords Prostate cancer, Androgen deprivation therapy, Immunotherapy, Nanotechnology, Biomaterials  \nIntroduction  \nAs the second most commonly occurring cancer in men, prostate cancer ranks among the top five leading causes of cancer-related fatalities worldwide [1]. Since earlystage prostate cancer often presents with insidious and mild symptoms, most male patients are diagnosed at  \n*Correspondence: Lang Rao[l rao@szbl.ac.cn](l rao@szbl.ac.cn)[ ](l rao@szbl.ac.cn)Qi Li [richee@zzu.edu.cn](richee@zzu.edu.cn)  \nFull list of author information is available at the end of the article  \nan advanced stage [2]. Although early-stage prostate cancer confined to the prostate tissue can be effectively treated through radical surgical resection, the majority of patients may still experience local recurrence and distant metastasis postoperatively, leading to a 5-year survival rate of just 14-34%[3]. Prostate cancer is a disease that relies on androgens for growth. The androgen receptor is expressed in almost all prostate cancer cells and the progression of this disease is largely dependent on androgen/ androgen receptor signaling, which means inhibiting the production of androgens or antagonizing the effects of androgen receptors in the body through endocrine therapy can achieve the purpose of treating prostate cancer  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use,","cbCaiszKJoC5ozC9","https://ap.wps.com/l/cbCaiszKJoC5ozC9","pdf",6386110,16,"English","# Abstract\n# Introduction\n## Prostate cancer burden and ADT rationale\n## ADT limitations: side effects and castration resistance","[{\"question\":\"Why is ADT important but limited in prostate cancer treatment?\",\"answer\":\"ADT is a mainstream approach because it lowers androgen levels and slows disease progression. However, systemic administration can produce significant side effects, and ADT can eventually fail due to castration-resistant progression.\"},{\"question\":\"What mechanisms are linked to ADT resistance in the tumor microenvironment?\",\"answer\":\"The document links resistance to NF-κB pathway activation and high infiltration of immunosuppressive M2 macrophages in the tumor microenvironment.\"},{\"question\":\"How does the hNVs@Flu-EGCG platform aim to improve therapeutic outcomes?\",\"answer\":\"The platform uses hybrid cellular nanovesicles to enhance tumor accumulation, load flutamide to act on androgen receptors, and apply EGCG to inhibit the NF-κB pathway, promote apoptosis, and reprogram M2 macrophages toward an antitumor M1 phenotype.\"}]","Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy | PDF",1790040431,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f27dc1b91545e57d9df4cf0f22f26ef.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92e85c259a75cdce0b1622c993251ca9.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41608783ff319867836cb8bb3e48b0f7.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/039aa01f30453b11c2e032732c8f4f46.webp",980,1306]